259 results match your criteria: "Asthma and Airway Disease Research Center.[Affiliation]"
People with obesity often have severe, difficult-to-control asthma. There is a need to develop better treatments for this population. One potential treatment is roflumilast, a phosphodiesterase 4 inhibitor, as it is reported to have efficacy for the treatment of asthma and can promote weight loss.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
January 2023
Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Berlin, Germany; University Hospital, Montpellier, France.
Chronic rhinitis encompassing both allergic and nonallergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated comorbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and nonallergic rhinitis, addressing the individual triggers of the disease as well as the patient-specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management, and treatment of nonallergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways, and digital health.
View Article and Find Full Text PDFAm J Respir Crit Care Med
February 2023
Division of Genetics, Genomics, and Precision Medicine, and.
CC16 is a protein mainly produced by nonciliated bronchial epithelial cells (BECs) that participates in host defense. Reduced CC16 protein concentrations in BAL and serum are associated with asthma susceptibility. Few studies have investigated the relationship between CC16 and asthma progression, and none has focused on BECs.
View Article and Find Full Text PDFFront Immunol
August 2022
Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Appropriate innate immune function is essential to limit pathogenesis and severity of severe lower respiratory infections (sLRI) during infancy, a leading cause of hospitalization and risk factor for subsequent asthma in this age group. Employing a systems biology approach to analysis of multi-omic profiles generated from a high-risk cohort (n=50), we found that the intensity of activation of an LPS-induced interferon gene network at birth was predictive of sLRI risk in infancy (AUC=0.724).
View Article and Find Full Text PDFLancet Respir Med
January 2023
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Background: Persistent airflow limitation (PAL) occurs in a subset of patients with asthma. Previous studies on PAL in asthma have included relatively small populations, mostly restricted to severe asthma, or have no included longitudinal data. The aim of this post-hoc analysis was to investigate the determinants, clinical implications, and outcome of PAL in patients with asthma who were included in the ATLANTIS study.
View Article and Find Full Text PDFAm J Respir Crit Care Med
March 2023
ISGlobal, Barcelona, Spain.
The identification of novel molecules associated with asthma may provide insights into the mechanisms of disease and their potential clinical implications. To conduct a screening of circulating proteins in childhood asthma and to study proteins that emerged from human studies in a mouse model of asthma. We included 2,264 children from eight birth cohorts from the Mechanisms of the Development of ALLergy project and the Tucson Children's Respiratory Study.
View Article and Find Full Text PDFFront Immunol
July 2022
Asthma and Airway Disease Research Center, University of Arizona Health Sciences, Tucson, AZ, United States.
Surfactant Protein-A (SP-A) is an innate immune modulator that regulates a variety of pulmonary host defense functions. We have shown that SP-A is dysfunctional in asthma, which could be partly due to genetic heterogeneity. In mouse models and primary bronchial epithelial cells from asthmatic participants, we evaluated the functional significance of a particular single nucleotide polymorphism of SP-A2, which results in an amino acid substitution at position 223 from glutamine (Q) to lysine (K) within the carbohydrate recognition domain (CRD).
View Article and Find Full Text PDFAllergy
December 2022
Asthma and Airway Disease Research Center, The University of Arizona, Tucson, Arizona, USA.
Background: The path to childhood asthma is thought to initiate in utero and be further promoted by postnatal exposures. However, the underlying mechanisms remain underexplored. We hypothesized that prenatal maternal immune dysfunction associated with increased childhood asthma risk (revealed by low IFN-γ:IL-13 secretion during the third trimester of pregnancy) alters neonatal immune training through epigenetic mechanisms and promotes early-life airway colonization by asthmagenic microbiota.
View Article and Find Full Text PDFChest
July 2022
Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ. Electronic address:
Semin Respir Crit Care Med
October 2022
Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Cells
June 2022
Department of Medicine and Center for Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
People with pre-existing lung diseases such as chronic obstructive pulmonary disease (COPD) are more likely to get very sick from SARS-CoV-2 disease 2019 (COVID-19). Still, an interrogation of the immune response to COVID-19 infection, spatially throughout the lung structure, is lacking in patients with COPD. For this study, we characterized the immune microenvironment of the lung parenchyma, airways, and vessels of never- and ever-smokers with or without COPD, all of whom died of COVID-19, using spatial transcriptomic and proteomic profiling.
View Article and Find Full Text PDFBr J Pharmacol
March 2023
Asthma and Airway Disease Research Center, University of Arizona Health Sciences Center, Tucson, Arizona, USA.
Background And Purpose: Asthma is a heterogenous disease strongly associated with inflammation that has many different causes and triggers. Current asthma treatments target symptoms such as bronchoconstriction and airway inflammation. Despite recent advances in biological therapies, there remains a need for new classes of therapeutic agents with novel, upstream targets.
View Article and Find Full Text PDFClin Infect Dis
October 2022
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses continue to co-circulate, representing 2 major public health threats from respiratory infections with similar clinical presentations. SARS-CoV-2 and influenza vaccines can also now be co-administered. However, data on antibody responses to SARS-CoV-2 and influenza coinfection and vaccine co-administration remain limited.
View Article and Find Full Text PDFJ Asthma
March 2023
Department of Pediatrics, National Jewish Health, Denver, CO, USA.
Objective: The first case of COVID-19 on the Navajo Nation (NN) was found on March 17, 2020. Even with strong public health efforts, NN saw the highest per capita infection rate in the US during May of 2020 with 2450/100,000. To determine the impact of COVID-19 on families of children with asthma on the NN, families participating in the NHLBI funded Community Asthma Program were contacted to see if they would share their experiences.
View Article and Find Full Text PDFJ Sch Nurs
August 2024
Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Asthma morbidity disproportionately impacts children from low-income and racial/ethnic minority communities. School-supervised asthma therapy improves asthma outcomes for up to 15 months for underrepresented minority children, but little is known about whether these benefits are sustained over time. We examined the frequency of emergency department (ED) visits and hospital admissions for 83 children enrolled in Asthma Link, a school nurse-supervised asthma therapy program serving predominantly underrepresented minority children.
View Article and Find Full Text PDFSleep Breath
May 2023
Department of Electrical and Computer Engineering, The University of Arizona, 1230 E Speedway Blvd, Tucson, AZ, 85719, USA.
Purpose: This study aimed to develop a machine learning-based questionnaire (BASH-GN) to classify obstructive sleep apnea (OSA) risk by considering risk factor subtypes.
Methods: Participants who met study inclusion criteria were selected from the Sleep Heart Health Study Visit 1 (SHHS 1) database. Other participants from the Wisconsin Sleep Cohort (WSC) served as an independent test dataset.
J Allergy Clin Immunol Glob
May 2022
Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Calif.
J Cyst Fibros
September 2022
Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, United States; Department of Medicine, University of Arizona, Tucson, AZ, United States. Electronic address:
Background: Club cell secretory protein (CC16) exerts anti-inflammatory functions in lung disease. We sought to determine the relation of serum CC16 deficits and genetic variants that control serum CC16 to lung function among children with cystic fibrosis (CF).
Methods: We used longitudinal data from CF children (EPIC Study) with no positive cultures for Pseudomonas aeruginosa prior to enrollment.
Implement Sci Commun
March 2022
Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, S5-828, 55 Lake Ave N, Worcester, MA, 01655, USA.
Background: Implementation science frameworks advise the engagement of multi-level partners (at the patient, provider, and systems level) to adapt and increase the uptake of evidence-based practices (EBPs). However, there is little guidance to ensure that systems-level adaptations reflect the voices of providers who deliver and patients/caregivers who receive EBPs.
Methods: We present a novel methodology, grounded in the Consolidated Framework for Implementation Research (CFIR), which anchors the engagement of multi-level partners to the voices of individuals who deliver and receive EBPs.
Int J Environ Res Public Health
March 2022
School of Public Health, San Diego State University, San Diego, CA 92182, USA.
Background: Neighborhood-scale air pollution sampling methods have been used in a range of settings but not in low air pollution airsheds with extreme weather events such as volatile precipitation patterns and extreme summer heat and aridity-all of which will become increasingly common with climate change. The desert U.S.
View Article and Find Full Text PDFInfect Immun
April 2022
Department of Immunobiology, University of Arizonagrid.134563.6 College of Medicine-Tucson, Tucson, Arizona, USA.
Streptococcus pneumoniae is a Gram-positive, encapsulated bacterium that is a significant cause of disease burden in pediatric and elderly populations. The rise in unencapsulated disease-causing strains and antimicrobial resistance in S. pneumoniae has increased the need for developing new antimicrobial strategies.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
June 2022
Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, Vt. Electronic address:
Background: Weight loss might improve asthma control in people with obesity. However, people with asthma might have particular challenges losing weight and the amount of weight loss needed to improve asthma control is not clear.
Objectives: To pilot-test an online weight loss intervention and to estimate the impact of weight loss on asthma control.
BMC Genomics
March 2022
Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
Background: The "Assay for Transposase Accessible Chromatin sequencing" (ATAC-seq) is an efficient and easy to implement protocol to measure chromatin accessibility that has been widely used in multiple applications studying gene regulation. While several modifications or variants of the protocol have been published since it was first described, there has not yet been an extensive evaluation of the effects of specific protocol choices head-to-head in a consistent experimental setting. In this study, we tested multiple protocol options for major ATAC-seq components (including three reaction buffers, two reaction temperatures, two enzyme sources, and the use of either native or fixed nuclei) in a well-characterized cell line.
View Article and Find Full Text PDFEur Respir J
March 2022
Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, USA